Compare BCRX & FA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | FA |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1995 | 2021 |
| Metric | BCRX | FA |
|---|---|---|
| Price | $9.52 | $11.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $20.82 | $15.67 |
| AVG Volume (30 Days) | ★ 5.9M | 1.2M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 72.97 |
| EPS | ★ 1.21 | N/A |
| Revenue | $25,186,000.00 | ★ $1,574,389,000.00 |
| Revenue This Year | N/A | $8.42 |
| Revenue Next Year | $12.55 | $7.26 |
| P/E Ratio | $7.83 | ★ N/A |
| Revenue Growth | N/A | ★ 83.02 |
| 52 Week Low | $6.00 | $8.82 |
| 52 Week High | $11.31 | $19.01 |
| Indicator | BCRX | FA |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 56.66 |
| Support Level | $7.85 | $10.28 |
| Resistance Level | $10.32 | $14.56 |
| Average True Range (ATR) | 0.60 | 0.58 |
| MACD | -0.03 | 0.12 |
| Stochastic Oscillator | 65.44 | 92.75 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.